| 中文名称 | 天冬氨酸 |
|---|---|
| 中文别名 | 天冬氨酸;L-天门冬氨酸;氨基丁二酸 L-天冬氨酸;氨基丁二酸;氨基琥珀酸;天门冬氨酸;门冬氨酸;L-天冬氨酸 |
| 英文名称 | Acidum asparticum |
| 英文别名 | ACIDUM ASPARTICUM;ASP;ASPARTIC ACID;ASPARTIC ACID, L-;ASPARTIC(L-);FEMA 3656;H-ASP-OH;H-L-ASP-OH;L-2-AMINOBUTANEDIOIC ACID;L-ALPHA-AMINOSUCCINIC ACID;L-AMINOSUCCINIC ACID;L-ASP;L-ASPARAGINIC ACID;L-ASPARATATE;L-ASPARGINE;(+)-L-ASPARTIC ACID;L-(+)-ASPARTIC ACID;L-ASPARTIC ACID;(S)-2-AMINOSUCCINIC ACID;(S)-AMINOBUTANEDIOIC ACID;[2R-[2alpha[2S*(3R*,4S*,5S*,7R*)3S*,5S*],5alpha,6beta]]-6-[7-[5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-3-methylsalicylic acid;6-{7-[(5S)-5-((6S,5R)-5-Ethyl-5-hydroxy-6-methylperhydro-2H-pyran-2-yl)-5-ethyl-3-methyloxolan-2-yl](4S,5S,3R,7R)-4-hydroxy-3,5-dimethyl-6-oxononyl}-2-hydroxy-3-methylbenzoic acid;Benzoic acid,6-(3R,4S,5S,7R)-;lasalocid (X 537 A);L-Aspartinsaeure;Aspartic acid [USAN:USP:INN];bmse000031;ASPARTIC ACID [EP IMPURITY];Aspartic acid (USP/INN);Tox21_500133;NCGC00024499-03;HB0374;L-Asparagic acid;L-[14C]aspartate;55443-54-4;ASPARTIC ACID [MART.];LYSINE ACETATE IMPURITY A [EP IMPURITY];AKOS006239578;Z995084132;NSC-3973;(S)-Aminosuccinic Acid;F8889-8684;Asparagic acid (VAN);Deamidated asparagine;Aminosuccinate;ASPARTIC ACID [VANDF];(2S)-2-azanylbutanedioic acid;[3H]-L-aspartic acid;4-04-00-02998 (Beilstein Handbook Reference);Acidum asparticum [INN-Latin];L-ASPARTIC ACID [FHFI];Asparagate;A824434;DB00128;(S)-(+)-Aspartate;(L)-ASPARTIC ACID;Aspartic acid, L- (8CI);L-ASPARTIC ACID [JAN];A 9256;L-Aspartic acid, SAJ special grade, >=99.0%;Aspartic acid, European Pharmacopoeia (EP) Reference Standard;ASPARTIC ACID (EP IMPURITY);CHEMBL274323;NCGC00024499-02;(2S)-Aspartate;SR-01000597734-3;L-Aspartic acid-13C4;ASPARTIC ACID (USP-RS);aspartate;NCGC00024499-06;D00013;DTXSID7022621;L-Aspartic acid, BioUltra, >=99.5% (T);L-Aspartic acid (H-Asp-OH) USP grade;alpha-Aminosuccinic acid;ASPARTIC ACID (II);EC 200-291-6;CHEBI:22660;56-84-8;A817928;D70832;SR-01000597734;bmse000875;L-Aspartic acid, 99.0%;Butanedioic acid, amino-, (S)-;BRN 1723530;Aspartic Acid (Aspartic Acid);L-Aspartic acid, Pharmaceutical Secondary Standard; Certified Reference Material;NCGC00024499-01;SDCCGSBI-0050121.P002;potassium aspartate and magnesium aspart;ALANINE IMPURITY A [EP IMPURITY];ASPARTIC ACID [USP MONOGRAPH];l-aspartic-acid;PDSP2_000806;ASPARTIC ACID [INN];C4H7NO4;L(+)-Aminobernsteinsaeure;EINECS 200-291-6;(S)-Aspartate;[3H]L-aspartic acid;HMS3260K08;(L)-Aspartate;S5632;L-Asparaginsaeure;Beta-L-Aspartic Acid;ALANINE IMPURITY A (EP IMPURITY);AKOS015853957;M03000;STR04614;Acide aspartique;alpha-Aminosuccinate;L-Aspartic acid, BioXtra, >=99% (HPLC);ASPARTIC ACID (EP MONOGRAPH);Asparaginic acid (VAN);aspartic acid,l;A0546;(R)-2-aminosuccinate;Aspartic acid, United States Pharmacopeia (USP) Reference Standard;(S)-Aspartic acid;Aspartic acid (VAN);L( )-Aminobernsteinsaeure;6899-03-2;Asparatate;BDBM18125;ASPARTIC ACID [EP MONOGRAPH];L-Aminosuccinate;... |
| CAS No. | 6899-03-2 |
| 分子式 | C4H7NO4 |
| 分子量 | 133.10 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学